{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:57:09Z","timestamp":1765727829251},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.prp.2017.03.011","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T01:15:13Z","timestamp":1490836513000},"page":"793-798","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology"],"prefix":"10.1016","volume":"213","author":[{"given":"Vincent","family":"Thomas De Montpr\u00e9ville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Rosa","family":"Ghigna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovic","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoinette","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Besse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9lie","family":"Fadel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Dorfmuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Le Chevalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2017.03.011_bib0005","series-title":"WHO Classification of Tumours of Lung, Pleura, Thymus and Heart","author":"Travis","year":"2015"},{"key":"10.1016\/j.prp.2017.03.011_bib0010","series-title":"WHO Classif. Tumours Lung Pleura Thymus Heart","first-page":"22","article-title":"Molecular testing for treatment selection in lung cancer","author":"Powell","year":"2015"},{"key":"10.1016\/j.prp.2017.03.011_bib0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.annpat.2015.11.005","article-title":"Strat\u00e9gie de testing mol\u00e9culaire des carcinomes pulmonaires","volume":"36","author":"Penault-Llorca","year":"2016","journal-title":"Ann. Pathol."},{"key":"10.1016\/j.prp.2017.03.011_bib0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/thoraxjnl-2014-206677","article-title":"Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group","volume":"71","author":"Dietel","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.prp.2017.03.011_bib0025","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(16)00004-0","article-title":"Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)","volume":"387","author":"Barlesi","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2017.03.011_bib0030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jmoldx.2013.03.001","volume":"15","author":"Linderman","year":"2013","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.prp.2017.03.011_bib0035","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3892\/or.2016.4874","article-title":"EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2387 cases from a single center","volume":"36","author":"Giannini","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2017.03.011_bib0040","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/JTO.0b013e3182a407fa","article-title":"Small-cell carcinoma in the setting of pulmonary adenocarcinoma: new insights in the era of molecular pathology","volume":"8","author":"Norkowski","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2017.03.011_bib0045","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/1078-0432.CCR-11-2109","article-title":"Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR\/KRAS and presence of PIK3CA\/AKT1 mutations","volume":"18","author":"Rekhtman","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2017.03.011_bib0050","series-title":"WHO Classif. Tumours Lung Pleura Thymus Heart","first-page":"26","article-title":"Adenocarconoma","author":"Travis","year":"2015"},{"key":"10.1016\/j.prp.2017.03.011_bib0055","first-page":"17","article-title":"Associations between the IASLC\/ATS\/ERS lung adenocarcinoma classification and EGFR and KRAS mutations","volume":"48","author":"Clay","year":"2016","journal-title":"Pathology (Phila.)"},{"key":"10.1016\/j.prp.2017.03.011_bib0060","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.prp.2016.06.005","article-title":"EGFR gene deregulation mechanisms in lung adenocarcinoma: a molecular review","volume":"212","author":"Tsiambas","year":"2016","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2017.03.011_bib0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cllc.2012.09.007","article-title":"KRAS mutations in lung cancer","volume":"14","author":"Karachaliou","year":"2013","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.prp.2017.03.011_bib0070","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/annonc\/mdv208","article-title":"Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer","volume":"26","author":"Lim","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2017.03.011_bib0075","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jmoldx.2010.11.010","article-title":"A platform for rapid detection of multiple oncogenic mutations with relevance to targeted therapy in non\u2013small-cell lung cancer","volume":"13","author":"Su","year":"2011","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.prp.2017.03.011_bib0080","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1093\/annonc\/mdr489","article-title":"Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice","volume":"22","author":"Sequist","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2017.03.011_bib0085","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cllc.2016.05.016","article-title":"EGFR testing in advanced non\u2013small-cell lung cancer, a mini-review","volume":"17","author":"Sheikine","year":"2016","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.prp.2017.03.011_bib0090","doi-asserted-by":"crossref","first-page":"26886","DOI":"10.18632\/oncotarget.4723","article-title":"BRAF mutation testing with a rapid, fully integrated molecular diagnostics system","volume":"6","author":"Janku","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2017.03.011_bib0095","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/jclinpath-2015-203345","article-title":"Automated PCR detection of BRAF mutations in colorectal adenocarcinoma: a diagnostic test accuracy study","volume":"69","author":"Colling","year":"2016","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2017.03.011_bib0100","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/jclinpath-2016-203696","article-title":"Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates","volume":"69","author":"de Biase","year":"2016","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2017.03.011_bib0105","doi-asserted-by":"crossref","first-page":"e0163444","DOI":"10.1371\/journal.pone.0163444","article-title":"Multi-center evaluation of the fully automated PCR-based Idylla\u00e4 KRAS Mutation Assay for rapid KRAS mutation status determination on formalin-fixed paraffin-embedded tissue of human colorectal cancer","volume":"11","author":"Solassol","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2017.03.011_bib0110","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jmoldx.2015.12.005","article-title":"Multicenter evaluation of a novel automated rapid detection system of BRAF status in formalin-fixed, paraffin-embedded tissues","volume":"18","author":"Schiefer","year":"2016","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.prp.2017.03.011_bib0115","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.yexmp.2015.09.004","article-title":"Multi-center evaluation of the novel fully-automated PCR-based Idylla\u2122 BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma","volume":"99","author":"Melchior","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.prp.2017.03.011_bib0120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jclinpath-2016-203989","article-title":"EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay","volume":"70","author":"De Luca","year":"2017","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2017.03.011_bib0125","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1309\/AJCPST1CTHZS3PSZ","article-title":"EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non\u2013small cell lung carcinoma than FISH, CISH, and immunohistochemistry","volume":"133","author":"Sholl","year":"2010","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2017.03.011_bib0130","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/jclinpath-2015-203348","article-title":"Diamond: immunohistochemistry versus sequencing in EGFR analysis of lung adenocarcinomas","volume":"69","author":"Ragazzi","year":"2016","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2017.03.011_bib0135","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/jclinpath-2016-203811","article-title":"Could molecular pathology testing in lung cancer be more cost-effective?","volume":"69","author":"Walsh","year":"2016","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2017.03.011_bib0140","doi-asserted-by":"crossref","first-page":"23874","DOI":"10.18632\/oncotarget.8074","article-title":"Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6595 lung cancers","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2017.03.011_bib0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4132\/jptm.2016.03.09","article-title":"Non-small cell lung cancer with concomitant EGFR, KRAS, and ALK mutation: clinicopathologic features of 12 cases","volume":"50","author":"Lee","year":"2016","journal-title":"J. Pathol. Transl. Med."},{"key":"10.1016\/j.prp.2017.03.011_bib0150","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/JTO.0b013e318283d958","article-title":"KRAS mutations as prognostic and predictive markers in non\u2013small cell lung cancer","volume":"8","author":"Martin","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2017.03.011_bib0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.lungcan.2016.01.002","article-title":"K-RAS mutations indicating primary resistance to crizotinib in ALK-rearranged adenocarcinomas of the lung: report of two cases and review of the literature","volume":"93","author":"Mengoli","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prp.2017.03.011_bib0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1183\/16000617.0071-2015","article-title":"KRAS oncogene in lung cancer: focus on molecularly driven clinical trials","volume":"25","author":"Kempf","year":"2016","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.prp.2017.03.011_bib0165","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1097\/JTO.0b013e3181f1c8de","article-title":"Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop","volume":"5","author":"Pirker","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2017.03.011_bib0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/JTO.0b013e318160c607","article-title":"Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma","volume":"3","author":"Marks","year":"2008","journal-title":"J. Thorac. Oncol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817302947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817302947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T16:34:43Z","timestamp":1601829283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033817302947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0344033817302947"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2017.03.011","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2017.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}